PAMERA Asset Management awarded letting instruction for the Frankfurt Börsentor

PAMERA Asset Management awarded letting instruction for the Frankfurt Börsentor

Frankfurt, 09 November 2010 – PAMERA Asset Management GmbH has been instructed by LaSalle Investment Management to let the planned »Börsentor« project in Frankfurt. The owner of the Börsentor is the LaSalle German Income and Growth Fund, a closed-end real estate fund with a total volume of approx. 1 billion euros, invested in German commercial property.

Uwe Rempis, Head of Asset Management Northern Europe for LaSalle Investment Management, explained the decision to instruc

AiCuris Presents Preclinical and Phase 1 Data of its anti-HSV drug AIC316

AiCuris announced today the presentation of preclinical and Phase 1 data on AIC316 at the Antivirals Congress in Amsterdam, Netherlands, from 7th – 9th of November 2010. AIC316 is a novel anti-HSV drug currently in clinical phase 2 testing.
AiCuris scientist and project leader Dr. Alexander Birkmann will give an overview on the pharmacokinetic-pharmacodynamic relationship of AIC316 by presenting efficacy data from experiments performed in a murine infection model and Phase 1 pharmacokin